Date | Price Target | Rating | Analyst |
---|---|---|---|
10/6/2021 | $12.00 → $5.00 | Neutral | Citigroup |
10/5/2021 | $8.50 → $5.50 | Buy → Neutral | BofA Securities |
9/8/2021 | $8.50 | Buy | BofA Securities |
8/5/2021 | $11.00 | Neutral | Citigroup |
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the second quarter ended June 30, 2024. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business update today, August 12, 2024, at 4:30 p.m. ET. Q2 2024 Financial Highlights: Obtained CE Medical certification for UK and Europe, launching Dream Sock across major European markets. Q2 Revenue was approximately $20.7 million, up approximately 58% year over year. Q2 Gr
Owlet to Report Second Quarter 2024 Financial Results on August 12, 2024 Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announced that Kate Scolnick, Chief Financial Officer ("CFO"), will be departing the Company to pursue other opportunities. Amanda Twede Crawford, Owlet's Vice President, Financial Planning and Analysis, will assume the role of CFO. Kate will remain at the Company in an advisory role for a transition period through September 2024. "On behalf of the Board of Directors and Owlet, I want to thank Kate for her executive leadership and significant contributions since joining our management team prior to our initial public l
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the first quarter ended March 31, 2024. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Kate Scolnick, will host a conference call to review the Company's results and provide a business update today, May 6, 2024, at 4:30 p.m. ET. Q1 2024 Financial Highlights: Q1 Revenue was approximately $14.8 million, up approximately 37% year over year. Q1 Gross Margin was approximately 44.4%, up 570 basis points year over year. Q1 Net Income was approximately $3.3 million,
Citigroup reiterated coverage of Owlet with a rating of Neutral and set a new price target of $5.00 from $12.00 previously
BofA Securities downgraded Owlet from Buy to Neutral and set a new price target of $5.50 from $8.50 previously
BofA Securities initiated coverage of Owlet with a rating of Buy and set a new price target of $8.50
8-K - Owlet, Inc. (0001816708) (Filer)
424B5 - Owlet, Inc. (0001816708) (Filer)
FWP - Owlet, Inc. (0001816708) (Subject)
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
Owlet (NYSE:OWLT) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.14) by 178.57 percent. The company reported quarterly sales of $14.800 million which missed the analyst consensus estimate of $16.430 million by 9.92 percent. This is a 38.32 percent increase over sales of $10.700 million the same period last year.
The Company closed on $11.6 million in proceeds from the underwritten public offering and up to $35 million in proceeds from the debt refinancing. Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announced the closing of its underwritten public offering of 3,135,136 shares of the Company's Class A common stock (the "Offering"). The shares of Class A common stock were sold at a public offering price of $3.70 per share, before underwriting discounts and commissions. All of the shares in the Offering were sold by the Company. The gross proceeds to Owlet from the Offering were approximately $11.6 million, before deducting underwriting discounts
The Company anticipates receiving $11.6 million in proceeds from the underwritten public offering and up to $35 million in proceeds from the debt refinancing. Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announced the pricing of an underwritten public offering of 3,135,136 shares of the Company's Class A common stock (the "Offering"). The shares of Class A common stock are being sold at a public offering price of $3.70 per share, before underwriting discounts and commissions. All of the shares in the Offering are to be sold by the Company. The gross proceeds to Owlet from the Offering are expected to be approximately $11.6 million, befor
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announced it intends to offer and sell its Class A common stock in an underwritten public offering. In addition, the Company intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the gross proceeds of its Class A common stock at the public offering price per share, before underwriting discounts and commissions. All of the shares in the proposed offering are to be sold by the Company. Owlet intends to use the net proceeds from the proposed public offering for general corporate purposes, capital expenditures, working capital and general and administrative expens
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), a pioneer of smart baby monitoring, is on a mission to raise critical funds for research that could bring an end to sudden infant death syndrome (SIDS). Owlet is partnering in this effort with Dr. Carmel Harrington, Honorary Research Fellow at Sydney Children's Hospital Westmead, and Elisha Palmer of Knox Blocks Foundation, both of whom are parents that have lost a child to SIDS. Sudden unexpected infant death (SUID), which includes SIDS, claims the lives of more than 3,000 babies each year in the U.S. alone1. The rate of SIDS is on the rise in the U.S.2 – making it one of the leading causes of infant mortality3. Despite this, there is m
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), a pioneer of smart baby monitoring, today announces the appointment of Marc Stoll to the Company's Board of Directors. Stoll is currently an Investment Partner at Eclipse, a strategic investment firm focused on advancing the Industrial Evolution. His experience spans more than 25 years across the global finance and technology industries, and his expertise in leading corporate strategy and operational excellence will help bolster Owlet's future ventures and growth potential. "I'm thrilled to join Owlet's Board of Directors after spending time becoming very familiar with the brand and products, its life-changing mission and amazing custome
Owlet, Inc. (NYSE:OWLT, "the Company"))), the pioneer of smart baby monitoring, is pleased to announce the addition of Melissa Gonzales to the Company's Board of Directors. Gonzales brings more than 20 years of consumer and provider healthcare experience to Owlet, further advancing the Company as a leader in infant monitoring solutions. "Owlet's growth proposition to facilitate change in health equity through its innovation in connected digital monitoring is extremely exciting," said Melissa Gonzales. "Creating meaningful momentum and impact within these trends is important to me personally and professionally and I am looking forward to contributing my experience towards supporting Owlet'
SC 13D/A - Owlet, Inc. (0001816708) (Subject)
SC 13D/A - Owlet, Inc. (0001816708) (Subject)
SC 13D/A - Owlet, Inc. (0001816708) (Subject)